159 related articles for article (PubMed ID: 8613907)
21. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
[TBL] [Abstract][Full Text] [Related]
22. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
[TBL] [Abstract][Full Text] [Related]
23. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
24. Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice.
Fredriksson A; Eriksson P; Archer T
J Neural Transm (Vienna); 2006 Feb; 113(2):137-50. PubMed ID: 16082515
[TBL] [Abstract][Full Text] [Related]
25. NMDA receptor blockade attenuates the haloperidol induction of Fos protein in the dorsal but not the ventral striatum.
de Souza IE; Meredith GE
Synapse; 1999 Jun; 32(4):243-53. PubMed ID: 10332800
[TBL] [Abstract][Full Text] [Related]
26. Chronic treatments with haloperidol and clozapine alter the level of NMDA-R1 mRNA in the rat brain: an in situ hybridization study.
Ossowska K; Pietraszek M; Wardas J; Dziedzicka-Wasylewska M; Nowicka D; Wolfarth S
Pol J Pharmacol; 2002; 54(1):1-9. PubMed ID: 12020038
[TBL] [Abstract][Full Text] [Related]
27. Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions.
Arif M; Chikuma T; Ahmed MM; Yoshida S; Kato T
Neurosci Res; 2007 Feb; 57(2):248-58. PubMed ID: 17141345
[TBL] [Abstract][Full Text] [Related]
28. Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6-OHDA lesion.
Meshul CK; Allen C
Synapse; 2000 May; 36(2):129-42. PubMed ID: 10767060
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of N-methyl-D-aspartate (NMDA) immunoreactivity in residual dendritic spines in the caudate-putamen nucleus after chronic haloperidol administration.
Rodríguez JJ; Pickel VM
Synapse; 1999 Sep; 33(4):289-303. PubMed ID: 10421710
[TBL] [Abstract][Full Text] [Related]
30. [Influence of the intracaudate administration of kainic acid on the effects of the prolonged use of haloperidol and apomorphine on rats].
Zharkovskiĭ AM; Allikmets LKh; Nurk AM
Farmakol Toksikol; 1982; 45(1):10-2. PubMed ID: 7198997
[TBL] [Abstract][Full Text] [Related]
31. Ontogeny of the effect of antipsychotic drug treatment on neurotensin concentrations in the rat brain.
Kinkead B; Owens MJ; Nemeroff CB
Synapse; 1995 Jul; 20(3):244-8. PubMed ID: 7570356
[TBL] [Abstract][Full Text] [Related]
32. Involvement of the dopaminergic system in the regulation of the caudate spindle in the rat.
Kamata K; Aoki H; Kameyama T
Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):228-35. PubMed ID: 6125131
[TBL] [Abstract][Full Text] [Related]
33. Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antipsychotic drugs.
Bauer R; Mayr A; Lederer W; Needham PL; Kilpatrick IC; Fleischhacker WW; Marksteiner J
Neuropsychopharmacology; 2000 Jul; 23(1):46-55. PubMed ID: 10869885
[TBL] [Abstract][Full Text] [Related]
34. [Nonuniform effect of cataleptogenic and atypical neuroleptics on the turning reactions induced by stimulation of the putamen and caudate nucleus in cats].
Anokhov SS; Arushanian EB
Farmakol Toksikol; 1984; 47(6):16-20. PubMed ID: 6151517
[TBL] [Abstract][Full Text] [Related]
35. Substance P levels in the rat forebrain after apomorphine and haloperidol treatment.
Janicki P; Lypko A; Szczudlik A; Libich J
Pol J Pharmacol Pharm; 1981; 33(5):499-502. PubMed ID: 6174959
[TBL] [Abstract][Full Text] [Related]
36. [The effect of halothane anesthesia on dopamine release induced by apomorphine or haloperidol--an in vivo microdialysis study in rats striatum].
Adachi Y; Wada H; Higuchi H; Watanabe K; Satoh T
Masui; 2001 Oct; 50(10):1089-95. PubMed ID: 11712340
[TBL] [Abstract][Full Text] [Related]
37. The effect of apomorphine and haloperidol on the RNA content of brain structures of the rat.
Izquierdo I; Schutz R; Prado de Carvalho L
Arch Int Pharmacodyn Ther; 1976 Dec; 224(2):258-62. PubMed ID: 1015923
[TBL] [Abstract][Full Text] [Related]
38. Chronic haloperidol-induced changes in regional dopamine release and metabolism and neurotensin content in rats.
See RE; Lynch AM; Aravagiri M; Nemeroff CB; Owens MJ
Brain Res; 1995 Dec; 704(2):202-9. PubMed ID: 8788915
[TBL] [Abstract][Full Text] [Related]
39. Effects of the isomers of N-n-propylnorapomorphine and haloperidol on regional concentrations of neurotensin in rat brain.
Nemeroff CB; Kilts CD; Levant B; Bissette G; Campbell A; Baldessarini RJ
Neuropsychopharmacology; 1991 Jan; 4(1):27-33. PubMed ID: 1672249
[TBL] [Abstract][Full Text] [Related]
40. [The behavioral and neurochemical changes in rats caused by the subchronic administration of haloperidol].
Shevchenko TP; Tolpyshev BA; Zban' LN
Eksp Klin Farmakol; 1993; 56(3):15-7. PubMed ID: 8219980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
